Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Focuses Research Activities on Novel NO-Donating PDE5 Inhibitors for Glaucoma and Enters into Collaboration with Novaliq on Innovative Topical Ophthalmic Formulations

December 21, 2018

View Press Release Corporate presentation Contact us
Previous